Amundi Asset Management US’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Amundi Asset Management US's ELV Position: Q1 2021 in Review
Amundi Asset Management US increased its Elevance Health (ELV) stake by 4.4% in Q1 2021, buying an estimated $10.2M and bringing the position to 756,900 shares worth $272M. The position accounts for 0.21% of the portfolio, ranked #110.
Amundi Asset Management US first reported a position in ELV in Q2 2017 and has held it in 16 quarters since. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.
- Amundi Asset Management US held 756,900 shares of Elevance Health worth $272M as of Q1 2021.
- Amundi Asset Management US bought 31,621 Elevance Health shares in Q1 2021, an estimated $10.2M.
- Elevance Health made up 0.21% of Amundi Asset Management US's portfolio in Q1 2021, its #110 holding.
- Amundi Asset Management US first reported a position in Elevance Health in Q2 2017 and has held it in 16 quarters since.
- 1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.